![David Bonita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Bonita
Directeur/Membre du Conseil chez
THIRD HARMONIC BIO, INC.
Fortune : 2 229 $ au 31/05/2026
Profil
David P.
Bonita currently serves as Independent Director at Acutus Medical, Inc. since 2016, Lead Independent Director at ImageneBio, Inc. starting in 2025, Independent Director at Prelude Therapeutics, Inc. since 2016, Independent Director at Third Harmonic Bio, Inc. since 2020, Director at Treeline Biosciences, Inc., General Partner at OrbiMed Advisors Private Equity since 2020, Member at Orbimed Private Investments VII LP, and Secretary at Auraeda, Inc. since 2021.
Former roles include Chairman at Clementia Pharmaceuticals, Inc. from 2014 to 2019, Independent Director at Ambit Biosciences Corp.
from 2012 to 2014, Independent Non-Executive Director at ViewRay Technologies, Inc., Director at Edwards Lifesciences CardiaQ LLC, Independent Director at SI-BONE, Inc. from 2014 to 2019, Independent Director at ViewRay, Inc. from 2015 to 2018, Independent Director at Tricida, Inc. from 2014 to 2023, Independent Director at Repare Therapeutics, Inc. from 2019 to 2026, Director at Enobia Pharma, Inc., Director at Imaxio SA, Director at Keystone Heart Ltd., Director at Sublimity Therapeutics Ltd., Independent Director at Loxo Oncology, Inc. from 2013 to 2017, Independent Director at Ikena Oncology, Inc., Independent Director at Imara, Inc., Director at Cryterion Medical, Inc., Finance Analyst at Morgan Stanley, and Finance Analyst at UBS Securities LLC.
Education includes an MBA and doctorate from The Trustees of Columbia University in The City of New York, both conferred in 2004, and an undergraduate degree from Harvard University conferred in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0 % | 16/06/2026 | 379 ( 0 % ) | 2 229 $ | 31/05/2026 |
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
ACUTUS MEDICAL, INC. 0,07 % | 01/02/2025 | 20 822 ( 0,07 % ) | - $ | 31/05/2026 |
Postes actifs de David Bonita
| Sociétés | Poste | Début |
|---|---|---|
| ACUTUS MEDICAL, INC. | Directeur/Membre du Conseil | 01/03/2016 |
| PRELUDE THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 01/07/2016 |
| THIRD HARMONIC BIO, INC. | Directeur/Membre du Conseil | 01/07/2020 |
Orbimed Private Investments VII LP
 Orbimed Private Investments VII LP Investment ManagersFinance Acts as Private Equity Fund | Corporate Officer/Principal | - |
Auraeda, Inc. | Secrétaire Général | 01/10/2021 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Develops molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates for cancer, autoimmune and neurological diseases | Directeur/Membre du Conseil | - |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01/12/2007 |
Anciens postes connus de David Bonita
| Sociétés | Poste | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 28/01/2026 |
| TRICIDA, INC. | Directeur/Membre du Conseil | 23/01/2023 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de David Bonita
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
ViewRay Technologies, Inc.
 ViewRay Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops radiation therapy technology for the treatment of cancer | Commercial Services |
Edwards Lifesciences CardiaQ LLC
 Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement | Health Technology |
SI-BONE, Inc.
 SI-BONE, Inc. Medical SpecialtiesHealth Technology Operates as a sacroiliac joint medical device company | Health Technology |
Acutus Medical, Inc.
 Acutus Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices and electrophysiology equipment | Health Technology |
ViewRay, Inc.
 ViewRay, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets the meridian radiation therapy system | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Develops biopharmaceutical products | Health Technology |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Develops and manufactures cerebral protection devices | Health Technology |
Sublimity Therapeutics Ltd.
 Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Ikena Oncology, Inc.
 Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Cryterion Medical, Inc.
 Cryterion Medical, Inc. Medical/Nursing ServicesHealth Services Operates a medical laboratory that utilizes cryoablation platform | Health Services |
Orbimed Private Investments VII LP
Orbimed Private Investments VII LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Develops molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates for cancer, autoimmune and neurological diseases | Health Technology |
Auraeda, Inc. |
